NEW industry report: Technology and Investments - Pharma Business Study Key Findings

Reuters Events Pharma surveyed over 260 pharmaceutical executives from across commercial and marketing, to help guide your next digital sales and technology adoption strategy.

Here’s a snapshot of the findings in this new report: 

  • 36% of respondents are “early majority” (adopt new technology after it has been successfully implemented elsewhere) and 34% “late majority” (has become mainstream) when it comes to adopting new technology.
  • 78% report an increase in their virtual sales force between 2019-22, with most 52% considering it to have a positive impact on sales.
  • 47% of companies have invested in technologies for omnichannel, with 42% of companies investing in customer relationship management (CRM) technologies.

Download the report to see how technology is helping companies navigate change and maintain customer centricity >>>

Please subscribe to view the analysis report